The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
Open accessAbstract
This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of antimicrobial therapy.The multifaceted nature of antimicrobial stewardship has led to collaborative review and support of these recommendations by the following organizations: American Academy of Pediatrics, American Society of Health-System Pharmacists, Infectious Diseases Society for Obstetrics and Gynecology, Pediatric Infectious Diseases Society, Society for Hospital Medicine, and Society of Infectious Diseases Pharmacists.The primary goal of antimicrobial stewardship is to optimize clinical outcomes while minimizing unintended consequences of antimicrobial use, including toxicity, the selection of pathogenic organisms (such as Clostridium difficile), and the emergence of resistance.Thus, the appropriate use of antimicrobials is an essential part of patient safety
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
To Err Is Human: Building a Safer Health System
(2000) · National Academies Press eBooks · doi:10.17226/9728 · Cited by 14,044
Crossing the Quality Chasm: A New Health System for the 21st Century
Baker, A. (2001) · BMJ · doi:10.1136/bmj.323.7322.1192 · Cited by 10,736
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors
Koppel, R. (2005) · JAMA · doi:10.1001/jama.293.10.1197 · Cited by 2,126
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
The Timing of Prophylactic Administration of Antibiotics and the Risk of Surgical-Wound Infection
Classen, D. C., Evans, R. S., Pestotnik, S. L., Horn, S. D., Menlove, R. L., & Burke, J. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260501 · Cited by 1,739
Self-citationChastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Chassin, M. R. (1998) · JAMA · doi:10.1001/jama.280.11.1000 · Cited by 1,262
Do Practice Guidelines Guide Practice?
Lomas, J., Anderson, G. M., Domnick-Pierre, K., Vayda, E., Enkin, M. W., & Hannah, W. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211906 · Cited by 1,234
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
Ledell, K., Muto, C. A., Jarvis, W. R., & Farr, B. M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502924 · Cited by 1,192
Infection Control — A Problem for Patient Safety
Burke, J. P. (2003) · New England Journal of Medicine · doi:10.1056/nejmhpr020557 · Cited by 1,167
Self-citationA Computer-Assisted Management Program for Antibiotics and Other Antiinfective Agents
Evans, R. S., Pestotnik, S. L., Classen, D. C., Clemmer, T. P., Weaver, L. K., Orme, J. F., Lloyd, J. F., & Burke, J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380406 · Cited by 1,061
Self-citationSINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Dale, W. B., Peter, M. H., & Workgroup, F. T. S. I. P. G. W. (2004) · Clinical Infectious Diseases · doi:10.1086/421095 · Cited by 878
Fagon, J.-Y., Chastre, J., Wolff, M., Gervais, C., Parer-Aubas, S., Stéphan, F., Similowski, T., Mercat, A., Diehl, J.-L., Sollet, J.-P., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00004 · Cited by 854
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Self-citationGoldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
A Controlled Trial of a Critical Pathway for Treatment of Community-Acquired Pneumonia
Marrie, T. J. (2000) · JAMA · doi:10.1001/jama.283.6.749 · Cited by 731
Antimicrobial Stewardship Programs in Health Care Systems
MacDougall, C., & Polk, R. E. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.638-656.2005 · Cited by 705
A COMPUTER-ASSISTED MANAGEMENT PROGRAM FOR ANTIBIOTICS AND OTHER ANTIINFECTIVE AGENTS
Vans, R. S. C. E., Estotnik, S. T. L. P., Lassen, D. A. C. C., Lemmer, T., Eaver, L. I. K. W., Rme, J. A. F. O., Loyd, J. A. F. L., & Urke, J. O. P. B. (1998) · Cited by 692
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Self-citationBoyce, J. M., Potter-Bynoe, G., Chenevert, C., & King, T. C. (1997) · Infection Control and Hospital Epidemiology · doi:10.2307/30141488 · Cited by 673
Rahal, J. J. (1998) · JAMA · doi:10.1001/jama.280.14.1233 · Cited by 642
Computerized Surveillance of Adverse Drug Events in Hospital Patients
Classen, D. C. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470200059035 · Cited by 639
Harbarth, S., Garbino, J., Pugin, J., Romand, J. A., Lew, D., & Pittet, D. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.005 · Cited by 637
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Paterson, D. L., Ko, W.-C., Gottberg, A. V., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00008 · Cited by 631
Self-citationAntimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use
McGowan, J. E. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.6.1033 · Cited by 605
Self-citationPestotnik, S. L., Classen, D. C., Evans, R. S., & Burke, J. P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-10-199605150-00004 · Cited by 590
Self-citationHilf, M., Yu, V. L., Sharp, J., Zuravleff, J. J., Korvick, J. A., & Muder, R. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90695-5 · Cited by 563
The impact of antibiotic use on resistance development and persistence
Barbosa, T. M., & Levy, S. B. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0167 · Cited by 493
Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 487
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
Ibrahim, E. H., Ward, S., Sherman, G., Schaiff, R., Fraser, V. J., & Kollef, M. H. (2001) · Critical Care Medicine · doi:10.1097/00003246-200106000-00003 · Cited by 478
“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy
Paterson, D. L. (2004) · Clinical Infectious Diseases · doi:10.1086/382690 · Cited by 466
Self-citationPaul, M., Benuri-Silbiger, I., Soares-Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 466
DiazGranados, C. A., Zimmer, S. M., Mitchel, K., & Jernigan, J. A. (2005) · Clinical Infectious Diseases · doi:10.1086/430909 · Cited by 459
Computer Technology and Clinical Work: Still Waiting for Godot
Wears, R. L., & Berg, M. (2005) · JAMA · doi:10.1001/jama.293.10.1261 · Cited by 448
Computer Physician Order Entry: Benefits, Costs, and Issues
Kuperman, G. J., & Gibson, R. F. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00010 · Cited by 438 · cited 1×
“CPOE has the potential to incorporate clinical decision support and to facilitate quality monitoring [138].”
BackgroundAn antibiotic policy to prevent emergence of resistant bacilli
de Man, P., Verhoeven, B., Verbrugh, H., Vos, M., & van den Anker, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90015-1 · Cited by 428
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years
Carling, P., Fung, T., Killion, A., Terrin, N., & Barza, M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502278 · Cited by 405
Clinical impact of rapid in vitro susceptibility testing and bacterial identification
Doern, G. V., Vautour, R., Gaudet, M., & Levy, B. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.7.1757-1762.1994 · Cited by 385
High Rates of Adverse Drug Events in a Highly Computerized Hospital
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1111 · Cited by 363 · cited 1×
“Despite being a model for implementing CPOE, one Veterans Administration hospital found a continuing high rate of adverse drug events in the absence of decision support for drug selection, dosing, and monitoring [153].”
MethodBergstrom, C. T., Lo, M., & Lipsitch, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402298101 · Cited by 359
Siberry, G. K., Tekle, T., Carroll, K., & Dick, J. (2003) · Clinical Infectious Diseases · doi:10.1086/377501 · Cited by 343
Chaix, C., Durand-Zaleski, I., Alberti, C., & Brun-Buisson, C. (1999) · JAMA · doi:10.1001/jama.282.18.1745 · Cited by 339
High‐Dose, Short‐Course Levofloxacin for Community‐Acquired Pneumonia: A New Treatment Paradigm
Dunbar, L. M., Wunderink, R. G., Habib, M. P., Smith, L. G., Tennenberg, A. M., Khashab, M. M., Wiesinger, B. A., Xiang, J. X., Zadeikis, N., & Kahn, J. B. (2003) · Clinical Infectious Diseases · doi:10.1086/377539 · Cited by 335
GRUSON, D., HILBERT, G., VARGAS, F., VALENTINO, R., BEBEAR, C., ALLERY, A., BEBEAR, C., GBIKPI-BENISSAN, G., & CARDINAUD, J.-P. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9905050 · Cited by 328
Quale, J., Landman, D., Saurina, G., Atwood, E., DiTore, V., & Patel, K. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.1020 · Cited by 306
Cosgrove, S. E., Kaye, K. S., Eliopoulous, G. M., & Carmeli, Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.2.185 · Cited by 299
KOLLEF, M. H., VLASNIK, J., SHARPLESS, L., PASQUE, C., MURPHY, D., & FRASER, V. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.9701046 · Cited by 295
Leibovici, L., Paul, M., Poznanski, O., Drucker, M., Samra, Z., Konigsberger, H., & Pitlik, S. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1127 · Cited by 280
Guide to Development of Practice Guidelines
Kish, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/319366 · Cited by 276
Vidal, F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440170139015 · Cited by 275
Economic Impact of Antimicrobial Resistance
McGowan, J. E. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010228 · Cited by 271
Self-citationAcademic Detailing to Improve Use of Broad-Spectrum Antibiotics at an Academic Medical Center
Solomon, D. H., Van Houten, L., Glynn, R. J., Baden, L., Curtis, K., Schrager, H., & Avorn, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.15.1897 · Cited by 270
Byl, B., Clevenbergh, P., Jacobs, F., Struelens, M. J., Zech, F., Kentos, A., & Thys, J. (1999) · Clinical Infectious Diseases · doi:10.1086/520182 · Cited by 266
Bantar, C., Sartori, B., Vesco, E., Heft, C., Saul, M., Salamone, F., & Oliva, M. E. (2003) · Clinical Infectious Diseases · doi:10.1086/375818 · Cited by 253
Antimicrobial use and bacterial resistance
Monroe, S., & Polk, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00129-6 · Cited by 247
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital
Gerding, D. N., Larson, T. A., Hughes, R. A., Weiler, M., Shanholtzer, C., & Peterson, L. R. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1284 · Cited by 246
Self-citationMelzer, M., Eykyn, S. J., Gransden, W. R., & Chinn, S. (2003) · Clinical Infectious Diseases · doi:10.1086/379321 · Cited by 241
Chatzinikolaou, I., Abi-Said, D., Bodey, G. P., Rolston, K. V. I., Tarrand, J. J., & Samonis, G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.501 · Cited by 238
John, J. F., & Fishman, N. O. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.471 · Cited by 238
Self-citationAntibiotic Resistance—Squeezing the Balloon?
Burke, J. P. (1998) · JAMA · doi:10.1001/jama.280.14.1270 · Cited by 237
Self-citationDecrease in Nosocomial Clostridium difficile–Associated Diarrhea by Restricting Clindamycin Use
Pear, S. M., Williamson, T. H., Bettin, K. M., Gerding, D. N., & Galgiani, J. N. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00003 · Cited by 235
Self-citationImpact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit
Raymond, D. P., Pelletier, S. J., Crabtree, T. D., Gleason, T. G., Hamm, L. L., Pruett, T. L., & Sawyer, R. G. (2001) · Critical Care Medicine · doi:10.1097/00003246-200106000-00001 · Cited by 233
Impact of a Hospital‐Based Antimicrobial Management Program on Clinical and Economic Outcomes
Gross, R., Morgan, A. S., Kinky, D. E., Weiner, M., Gibson, G. A., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/321880 · Cited by 230
Self-citationRobert, J., Fridkin, S. K., Blumberg, H. M., Anderson, B., White, N., Ray, S. M., Chan, J., & Jarvis, W. R. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501690 · Cited by 227
A Meta-Analysis of Extended-Interval Dosing Versus Multiple Daily Dosing of Aminoglycosides
Bailey, T. C., Little, J. R., Littenberg, B., Reichley, R. M., & Dunagan, W. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.786 · Cited by 222
Ansari, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg459 · Cited by 222
Bliziotis, I. A., Samonis, G., Vardakas, K. Z., Chrysanthopoulou, S., & Falagas, M. E. (2005) · Clinical Infectious Diseases · doi:10.1086/430912 · Cited by 219
Computer surveillance of hospital acquired infections and antibiotic use
(1987) · American Journal of Infection Control · doi:10.1016/0196-6553(87)90148-9 · Cited by 215
Korvick, J. A., Bryan, C. S., Farber, B., Beam, T. R., Schenfeld, L., Muder, R. R., Weinbaum, D., Lumish, R., Gerding, D. N., & Wagener, M. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2639 · Cited by 212
Self-citationReducing Vancomycin Use Utilizing a Computer Guideline: Results of a Randomized Controlled Trial
Shojania, K. G., Yokoe, D., Platt, R., Fiskio, J., Ma'luf, N., & Bates, D. W. (1998) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.1998.0050554 · Cited by 211
Computerized surveillance of adverse drug events in hospital patients
Classen, D. C. (2005) · Quality and Safety in Health Care · doi:10.1136/qshc.2002.002972 · Cited by 211
Hyle, E. P., Lipworth, A. D., Zaoutis, T. E., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1375 · Cited by 194
Antibiotic optimization. An evaluation of patient safety and economic outcomes
Fraser, G. L. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.15.1689 · Cited by 192
Enterococcus faecium Bacteremia: Does Vancomycin Resistance Make a Difference?
Stosor, V., Peterson, L. R., Postelnick, M., & Noskin, G. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.5.522 · Cited by 176
Development of resistance during antibiotic therapy
Milatovic, D., & Braveny, I. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02017607 · Cited by 174
Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
Salgado, C. D., & Farr, B. M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502271 · Cited by 159
Ramsay, C., Brown, E., Hartman, G., & Davey, P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg460 · Cited by 158
Computer Surveillance of Hospital-Acquired Infections and Antibiotic Use
Evans, R. S. (1986) · JAMA · doi:10.1001/jama.1986.03380080053027 · Cited by 157
A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century
Paskovaty, A., Pflomm, J.-M., Myke, N., & Seo, S. K. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.001 · Cited by 154
Rüttimann, S., Keck, B., Hartmeier, C., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380964 · Cited by 149
Development and Impact of a Computerized Pediatric Antiinfective Decision Support Program
Mullett, C. J., Evans, R. S., Christenson, J. C., & Dean, J. M. (2001) · PEDIATRICS · doi:10.1542/peds.108.4.e75 · Cited by 141
Systematic Review of Antimicrobial Drug Prescribing in Hospitals
Davey, P. G., Brown, E. M., Fenelon, L. E., Finch, R., Gould, I. M., Holmes, A. H., Ramsay, C. R., Taylor, E., Wiffen, P. J., & Wilcox, M. H. (2006) · Emerging infectious diseases · doi:10.3201/eid1202.050145 · Cited by 137
Woodward, R. S., Medoff, G., Smith, M. D., & Gray, J. L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90636-x · Cited by 129
Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline
Hindler, J. F., & Clinical (2005) · Clinical and Laboratory Standards Institute eBooks · Cited by 126
Paterson, D. L., & Rice, L. B. (2003) · Clinical Infectious Diseases · doi:10.1086/374243 · Cited by 126
Self-citationGrant, E. M., Kuti, J. L., Nicolau, D. P., Nightingale, C. H., & Quintiliani, R. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.7.471.33665 · Cited by 126
Schentag, J. J., Ballow, C. H., Fritz, A. L., Paladino, J. A., Williams, J. D., Cumbo, T. J., Ali, R. V., Galletta, V. A., Gutfeld, M. B., & Adelman, M. H. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90119-r · Cited by 122
Mario Calvo, A. (2004) · Revista chilena de infectología · doi:10.4067/s0716-10182004000400012 · Cited by 119
Polk, R. E., Johnson, C. K., McClish, D. K., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/422647 · Cited by 117
Chan, R., Hemeryck, L., O'Regan, M., et al. (1995) · BMJ · doi:10.1136/bmj.310.6991.1360 · Cited by 116
Lawton, R. M., Fridkin, S. K., Gaynes, R. P., et al. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501754 · Cited by 112
Lautenbach, E., LaRosa, L. A., Marr, A. M., Nachamkin, I., Bilker, W. B., & Fishman, N. O. (2003) · Clinical Infectious Diseases · doi:10.1086/346153 · Cited by 109
Self-citationKollef, M. H., & Kollef, K. E. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2706 · Cited by 101
Evaluation of a Computer-Assisted Antibiotic-Dose Monitor
Evans, R. S., Pestotnik, S. L., Classen, D. C., & Burke, J. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18391 · Cited by 100
Self-citationRifampicin Resistance in Tuberculosis Outbreak, London, England
Jenkins, C., Claxton, A. P., Shorten, R. J., McHugh, T. D., & Gillespie, S. H. (2005) · Emerging infectious diseases · doi:10.3201/eid1106.050118 · Cited by 97
Müller, A., Mauny, F., Bertin, M., Cornette, C., López-Lozano, J.-M., Viel, J., Talon, D. R., & Bertrand, X. (2003) · Clinical Infectious Diseases · doi:10.1086/374221 · Cited by 96
Hepatitis C Virus Infection in African Americans
Pearlman, B. L. (2005) · Clinical Infectious Diseases · doi:10.1086/498512 · Cited by 92
Price, J., Ekleberry, A., Grover, A. C., MELENDY, S., Baddam, K., McMahon, J., Villalba, M., Johnson, M. D., & Zervos, M. J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199910000-00007 · Cited by 89
Anglim, A. M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440310098010 · Cited by 88
Glowacki, R. C., Schwartz, D. N., Itokazu, G. S., Wisniewski, M. F., Kieszkowski, P., & Weinstein, R. A. (2003) · Clinical Infectious Diseases · doi:10.1086/376623 · Cited by 85
Self-citationOwens, R. C., Fraser, G. L., & Stogsdill, P. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.9.896.36101 · Cited by 81
Self-citationRole of Infectious Diseases Consultants in Management of Antimicrobial Use in Hospitals
Sunenshine, R. H., Liedtke, L. A., Jernigan, D. B., Strausbaugh, L. J., & the Infectious Diseases Society of America Emerging Infections Network (2004) · Clinical Infectious Diseases · doi:10.1086/382358 · Cited by 80
Li, J. Z., Willke, R. J., Rittenhouse, B., & Rybak, M. J. (2003) · Surgical Infections · doi:10.1089/109629603764655290 · Cited by 75
Toltzis, P., Yamashita, T. S., Vilt, L., Green, M., Morrissey, A. B., Spinner-Block, S., & Blumer, J. L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00035 · Cited by 71
Routine Cycling of Antimicrobial Agents as an Infection-Control Measure
Weinstein, R. A., & Fridkin, S. K. (2003) · Clinical Infectious Diseases · doi:10.1086/375082 · Cited by 65
Self-citationLong-term Amikacin Use: Effects on Aminoglycoside Susceptibility Patterns of Gram-Negative Bacilli
Moody, M. M. (1982) · JAMA · doi:10.1001/jama.1982.03330100037027 · Cited by 62
May, A. K., Melton, S. M., McGwin, G., Cross, J. M., Moser, S. A., & Rue, L. W. (2000) · Shock · doi:10.1097/00024382-200014030-00003 · Cited by 61
Antibiotic Resistance Patterns During Aminoglycoside Restriction
Young, E. J., Koza, M. A., Clarridge, J. E., & Sewell, C. M. (1985) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198512000-00001 · Cited by 57
Dunbar et al. (2003; 37:752-60)
(2003) · Clinical Infectious Diseases · doi:10.1086/379736 · Cited by 55
Controlling Use of Antimicrobial Agents
Herwaldt, L. A., & Duncan, R. A. (1997) · Infection Control and Hospital Epidemiology · doi:10.1086/647608 · Cited by 51
Damas, P., Garweg, C., Monchi, M., Nys, M., Canivet, J.-L., Ledoux, D., & Preiser, J. (2006) · Critical Care · doi:10.1186/cc4879 · Cited by 44
A simple intervention to improve hospital antibiotic prescribing
South, M., Royle, J., & Starr, M. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05163.x · Cited by 42
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
Chastre, J. E., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez‐Bermejo, J., Jusserand, D., Asfar, P., et al. (2007) · Cited by 39
McCollum, M., Rhew, D. C., & Parodi, S. M. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90101-9 · Cited by 34
Mullett, C. J., Thomas, J. G., Smith, C. L., Sarwari, A. R., & Khakoo, R. (2004) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2004.04.002 · Cited by 31
King, J. W., White, M. C., Todd, J. R., & Conrad, S. A. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.4.908 · Cited by 30
Antimicrobial management measures to limit resistance: A process-based conceptual framework
DeLisle, S., & Perl, T. M. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104001-00012 · Cited by 19
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Self-citationInterventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Metadata
- Authors
- Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., Brennan, P. J., Billeter, M., & Hooton, T. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-15
- Volume
- 44
- Issue
- 2
- Pages
- 159-177
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2168908910
- Cited by
- 3,362
- References
- 130
- FWCI
- 70.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.